Age-associated time delays in the treatment of acute myocardial infarction with primary percutaneous transluminal coronary angioplasty
Authors:
- David C. LeeDLDavid C. Lee
- Diana M. PancuDPDiana M. Pancu
- Gary S. RudolphGRGary S. Rudolph
- Andrew E. SamaASAndrew E. Sama
- 1 January 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 23 (1) , 20-23
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Thrombolytic therapy in older patientsJACC, 2000
- Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial InfarctionNew England Journal of Medicine, 1998
- Use of Reperfusion Therapy for Acute Myocardial Infarction in the United StatesCirculation, 1998
- Thrombolytic Therapy for Eligible Elderly Patients With Acute Myocardial InfarctionJAMA, 1997
- Determinants of Appropriate Use of Angiotensin-Converting Enzyme Inhibitors After Acute Myocardial Infarction in Persons ≥65 Years of AgeThe American Journal of Cardiology, 1997
- Aspirin for Secondary Prevention after Acute Myocardial Infarction in the Elderly: Prescribed Use and OutcomesAnnals of Internal Medicine, 1996
- Medical Therapy for Elderly Patients Who Have Had Myocardial Infarction: Too Little to the Late in Life?Annals of Internal Medicine, 1996
- Recent Age-Related Trends in the Use of Thrombolytic Therapy in Patients Who Have Had Acute Myocardial InfarctionAnnals of Internal Medicine, 1996
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994